Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial.

Omori S, Kenmotsu H, Nomura S, Harada H, Ishikura S, Konno M, Ando M, Izumi H, Shinno Y, Oki M, Masuda T, Yokoyama T, Hosomi Y, Nakamura Y, Murakami S, Kurosaki T, Yoshioka H, Azuma K, Tsubouchi K, Nokihara H, Miura S, Daga H, Yoshida H, Hirano S, Mitome N, Fukuda H, Okamoto I, Takahashi T

Open source

DOI: 10.1016/j.lungcan.2026.109583
Published: 2026 Oct
Container: Lung cancer (Amsterdam, Netherlands)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.lungcan.2026.109583,
  title = {Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial.},
  author = {Omori S and Kenmotsu H and Nomura S and Harada H and Ishikura S and Konno M and Ando M and Izumi H and Shinno Y and Oki M and Masuda T and Yokoyama T and Hosomi Y and Nakamura Y and Murakami S and Kurosaki T and Yoshioka H and Azuma K and Tsubouchi K and Nokihara H and Miura S and Daga H and Yoshida H and Hirano S and Mitome N and Fukuda H and Okamoto I and Takahashi T},
  year = {2026},
  journal = {Lung cancer (Amsterdam, Netherlands)},
  doi = {10.1016/j.lungcan.2026.109583},
  url = {https://doi.org/10.1016/j.lungcan.2026.109583}
}

RIS

TY  - JOUR
TI  - Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial.
AU  - Omori S
AU  - Kenmotsu H
AU  - Nomura S
AU  - Harada H
AU  - Ishikura S
AU  - Konno M
AU  - Ando M
AU  - Izumi H
AU  - Shinno Y
AU  - Oki M
AU  - Masuda T
AU  - Yokoyama T
AU  - Hosomi Y
AU  - Nakamura Y
AU  - Murakami S
AU  - Kurosaki T
AU  - Yoshioka H
AU  - Azuma K
AU  - Tsubouchi K
AU  - Nokihara H
AU  - Miura S
AU  - Daga H
AU  - Yoshida H
AU  - Hirano S
AU  - Mitome N
AU  - Fukuda H
AU  - Okamoto I
AU  - Takahashi T
PY  - 2026
JO  - Lung cancer (Amsterdam, Netherlands)
DO  - 10.1016/j.lungcan.2026.109583
UR  - https://doi.org/10.1016/j.lungcan.2026.109583
ER  -

APA

S, O., H, K., S, N., H, H., S, I., M, K., M, A., H, I., Y, S., M, O., T, M., T, Y., Y, H., Y, N., S, M., T, K., H, Y., K, A., K, T., H, N., S, M., H, D., H, Y., S, H., N, M., H, F., I, O., & T, T. (2026). Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial.. Lung cancer (Amsterdam, Netherlands). https://doi.org/10.1016/j.lungcan.2026.109583

Source records

pubmed · retrieved 2026-09-25T13:25:15.199Z